BioScrip Appoints Douglas Lee Chief Information Officer.ELMSFORD, N.Y. -- BioScrip, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BIOS), a comprehensive pharmaceutical care solutions company, has named Mr. Douglas Lee as its Vice President and Chief Information Officer, responsible for leading the Company's information technology function, defining and implementing BioScrip's strategic use of information technology, and ensuring that the technology investment is positioned to support BioScrip's growth and system. Mr. Lee was previously employed at Option Care, Inc. where he had served as its Chief Information Officer. Prior to Option Care, Inc., Mr. Lee was Chief Information Officer and Partner for Technology Extension Consulting, Inc, a national consulting practice, which provided interim senior level IT management for organizations. Mr. Lee has also held management positions in information technology in the telecommunications and telecommunications software industries. Mr. Lee earned his Masters in Business Administration from Aurora University For the defunct catholic university in Shanghai of the same name, see . Academics Aurora University is organized into three colleges: the College of Arts and Sciences, the College of Education, and the College of Professional Studies. and Bachelor of Arts in Strategic Planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. and Business Administration from Ripon College Ripon College can refer to:
"We are pleased to have Douglas Lee join our team at this critical time. Currently, BioScrip has been undertaking many steps to improve our corporate systems in order to both streamline and expand our capabilities," noted Mr. Richard H. Friedman, the Company's Chairman and Chief Executive Officer. "By utilizing Doug's expertise to direct our information technology efforts, BioScrip will be well positioned to build out the necessary infrastructure to support future growth." About BioScrip, Inc. BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: Specialty Medication Distribution and Clinical Management Services, both nationally and community-based, and Pharmacy Benefit Management A Pharmacy Benefit Manager (PBM) is a third party administrator of prescription drug programs. They are primarily responsible for processing and paying prescription drug claims. Services. Our specialty medication distribution capabilities include condition-specific clinical management programs tailored to improve the care of individuals with complex health conditions such as HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , Cancer, Infusion IVIG IVIG Intravenous immunoglobulin, see there , Hepatitis C Hepatitis C Definition Hepatitis C is a form of liver inflammation that causes primarily a long-lasting (chronic) disease. Acute (newly developed) hepatitis C is rarely observed as the early disease is generally quite mild. , Rheumatoid Arthritis rheumatoid arthritis Chronic, progressive autoimmune disease causing connective-tissue inflammation, mostly in synovial joints. It can occur at any age, is more common in women, and has an unpredictable course. , Multiple Sclerosis, and Transplantation. Our complete pharmacy benefit management programs include customized benefit plan design, pharmacy network management and sophisticated reporting capabilities that deliver improved clinical and economic outcomes. In addition, we have 35 locations including community and infusion pharmacies in major metropolitan markets across the U.S., providing nationwide access and clinical management capabilities in a high-touch community-based environment. Forward Looking Statements This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company, the Company's ability to continue improving the above identified trends and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion